Filing Flows

Filing Flows › IQVIA Holdings (IQV) › Q3 2026 › vs Q2 2026

IQVIA Holdings (IQV) Q3 2026 vs Q2 2026 (quarter over quarter)

IQVIA Holdings's revenue rose $60.0M (+1%) from $4.4B in Q2 2026 to $4.4B in Q3 2026. The biggest changes: Research & Development Solutions +$64.0M (+2%); Commercial Solutions −$4.0M (-0.2%). Operating margin 12.9% against 11.6% (+1.3 pts).

IQVIA Holdings, Q3 2026: revenue $4.4B (+8% year over year), operating margin 12.9%, net earnings $352M, operating cash flow $825M. The chart draws each line against Q2 2026, the increases inside each band.

IQVIA Holdings: what changed, Q3 2026 vs Q2 2026IQVIA Holdings: what changed, Q3 2026 vs Q2 2026Operating cash flow$267MWorking capital & other$156MPre-tax earnings$110MNet earnings$94.0MOperating profit$66.0MResearch & Development Soluti…$64.0MOther expense, net−$44.0MDepreciation & amortization$29.0MIncome tax$16.0MShare-based compensation−$12.0M

Margins

Q3 2026Q2 2026Change
Operating margin12.9%11.6%+1.3 pts
Net margin7.9%5.9%+2.0 pts

Every line

LineQ3 2026Q2 2026Change%
Research & Development Solutions$2.6B$2.6B$64.0M+2%
Commercial Solutions$1.8B$1.8B−$4.0M-0.2%
Revenue$4.4B$4.4B$60.0M+1%
Operating profit$572M$506M$66.0M+13%
Costs & expenses$3.9B$3.9B−$6.0M-0.2%
Pre-tax earnings$428M$318M$110M+35%
Other expense, net$144M$188M−$44.0M-23%
Cost of revenue$2.9B$2.9B−$3.0M-0.1%
SG&A$569M$574M−$5.0M-0.9%
Other operating costs$357M$355M$2.0M+0.6%
Net earnings$352M$258M$94.0M+36%
Income tax$76.0M$60.0M$16.0M+27%
Depreciation & amortization$321M$292M$29.0M+10%
Share-based compensation$83.0M$95.0M−$12.0M-13%
Working capital & other$69.0M−$87.0M$156M—
Operating cash flow$825M$558M$267M+48%

Questions

How much did IQVIA Holdings's revenue grow quarter over quarter in Q3 2026?

IQVIA Holdings's revenue rose $60.0M (+1%) from $4.4B in Q2 2026 to $4.4B in Q3 2026.

What drove IQVIA Holdings's revenue change in Q3 2026?

Research & Development Solutions +$64.0M (+2%); Commercial Solutions −$4.0M (-0.2%).

Q3 2026 results → · Compare in the interactive Sankey →